Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Global Clinical Trial Software Market 2023
... involved to evaluate the effectiveness, safety, and side effects of new drugs, medical devices, and treatments. Clinical trial software helps clinical research organizations and pharmaceutical companies to manage, track, and monitor all aspects of the ... Read More
-
Canada Medical Writing Market Size, Share & Trends Analysis Report By Type (Clinical, Regulatory, Scientific), By Application (Medical Journalism, Medico Marketing), By End-use, By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The Canada medical writing market size is expected to reach USD 262.7 million by 2030, expanding at a CAGR of 10.36% from 2023 to 2030, based on a new report by Grand ... Read More
-
Angelman Syndrome (AS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 313,981 diagnosed prevalent cases of AS in 2023 in the 16 major markets. The marketed drugs space for AS is poor as there are no therapies currently approved for the treatment of the disease. R&D ... Read More
-
Global Cell and Gene Therapy Clinical Trial Market 2023-2029
... cell therapy, cells are cultivated or modified outside the body before being injected into the patient. Gene therapy aims to treat diseases by replacing, inactivating or introducing genes into cells - either inside the body ... Read More
-
Is the Metaverse Virtually a Reality for Life Science R&D?
... the vendor landscape, reviews implementation challenges, and provides guidance to the technology buyer."As clinical trials go remote and the ask for the personal touch heightens, the metaverse will deepen patient engagement, shape patient behaviors, and ... Read More
-
Chemotherapy Drugs- Market Insights, Competitive Landscape, and Market Forecast - 2027
... Cancer, And Others), By Route Of Administration (Oral And Parenteral), by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to increasing prevalence of different cancer types and increasing pharmaceutical ... Read More
-
Global Clinical Trial Imaging Market Report, History and Forecast 2018-2029
... 2022, is projected to reach a revised size of US$ 2,208.53 million by 2029, growing at a CAGR of 6.93% during the forecast period 2023-2029. North American market for Clinical Trial Imaging was valued at ... Read More
-
Global Glycogen Storage Disorders (GSD) Clinical Trials Market Growth (Status and Outlook) 2023-2029
... world Glycogen Storage Disorders (GSD) Clinical Trials sales in 2022, providing a comprehensive analysis by region and market sector of projected Glycogen Storage Disorders (GSD) Clinical Trials sales for 2023 through 2029. With Glycogen Storage ... Read More
-
Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... markets, there were over 540 million individuals vaccinated against influenza in 2022. Globally, a high number of vaccines are approved and marketed for the prevention of influenza; AstraZeneca, Sanofi, and GSK are the top key ... Read More
-
Global Clinical Trial Supply Management Market Growth (Status and Outlook) 2023-2029
... & country approvals, and analytics. However, a partially pre-configured solution, hosted on a cloud, adds much more than the typical CTSM solutions to the value proposition for smaller but critical entities like CROs. Add to ... Read More
-
Heart Failure (HF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... million diagnosed prevalent cases of heart failure in the 16 major markets. There is a significant number of marketed innovator drugs for the treatment of HF, mostly belonging to enzyme inhibitors and receptor antagonists category. ... Read More
-
Essential Tremor (ET) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 6,000,000 diagnosed prevalent cases of ET in 2023 in the 16 major markets. The marketed drugs space for ET is widely genericized and is dominated by beta-blockers and anticonvulsants. R&D activity in ET is very ... Read More
-
Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Lupus Nephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 1.6 million diagnosed prevalent cases of ITP in 2023 across 16 pharmaceutical markets. There are four leading marketed innovator drugs for the treatment of ITP, majority of marketed products are thrombopoietin receptor agonist. R&D activity ... Read More
-
Parkinson's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Parkinson's Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Postherpetic Neuralgia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Postherpetic Neuralgia Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Cognitive Impairment Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Cognitive Impairment Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Thalassemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Thalassemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Thalassemia. Report includes ... Read More
-
Cellulitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Cellulitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Cellulitis. Report includes ... Read More
-
Malaria Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Malaria Clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes ... Read More
-
Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Kaposi Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Gastric Ulcers Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Gastric Ulcers Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Fragile X Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Fragile X Syndrome Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Non-Small Cell Lung Cancer (NSCLC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... and 10-year patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell & gene therapies by class, including early to late clinical stage pipeline products, with a ... Read More
-
Global Clinical Trial Supply & Logistics for Pharmaceutical Market Growth (Status and Outlook) 2023-2029
... and available infrastructures. Clinical Trial Supply and Logistic for Pharmaceutical management is imperative for avoiding overproduction, inventory expiration, and oversupply. With the escalating costs of drug discovery, Clinical Trial Supply and Logistic for Pharmaceutical is ... Read More
Research Assistance
